251 related articles for article (PubMed ID: 15224904)
1. [Recreational and designer drugs-the risks to heart and brain].
Nebelsieck H
MMW Fortschr Med; 2004 Apr; 146(17):40-2. PubMed ID: 15224904
[TBL] [Abstract][Full Text] [Related]
2. Recreational drugs. Societal and professional issues.
Solari-Twadell PA
Nurs Clin North Am; 1991 Jun; 26(2):499-509. PubMed ID: 2047294
[TBL] [Abstract][Full Text] [Related]
3. BZP-party pills: a review of research on benzylpiperazine as a recreational drug.
Cohen BM; Butler R
Int J Drug Policy; 2011 Mar; 22(2):95-101. PubMed ID: 21242080
[TBL] [Abstract][Full Text] [Related]
4. Out with the old, in with the new? Case reports of the clinical features and acute management of two novel designer drugs.
Misselbrook GP; Hamilton EJ
Acute Med; 2012; 11(3):157-60. PubMed ID: 22993747
[TBL] [Abstract][Full Text] [Related]
5. Clinical toxicology of newer recreational drugs.
Hill SL; Thomas SH
Clin Toxicol (Phila); 2011 Oct; 49(8):705-19. PubMed ID: 21970769
[TBL] [Abstract][Full Text] [Related]
6. [Neurologic complications of drug addiction. General aspects. Complications caused by cannabis, designer drugs and volatile substances].
Farre Albaladejo M
Arch Neurobiol (Madr); 1989; 52 Suppl 1():143-8. PubMed ID: 2700291
[TBL] [Abstract][Full Text] [Related]
7. Methylone and mCPP, two new drugs of abuse?
Bossong MG; Van Dijk JP; Niesink RJ
Addict Biol; 2005 Dec; 10(4):321-3. PubMed ID: 16318952
[TBL] [Abstract][Full Text] [Related]
8. Not so rave review. Club drugs in Minnesota.
Gaines S
Minn Med; 2001 Apr; 84(4):16-22. PubMed ID: 11367814
[No Abstract] [Full Text] [Related]
9. [Designer drugs and anesthesia].
Nogué S; Monsalve C
Rev Esp Anestesiol Reanim; 2005 Apr; 52(4):191-2. PubMed ID: 15901023
[No Abstract] [Full Text] [Related]
10. Recommendations for future research on amphetamines and related designer drugs.
Fuller RW
NIDA Res Monogr; 1989; 94():341-57. PubMed ID: 2514367
[No Abstract] [Full Text] [Related]
11. Chemical dependency and the heart.
Frost DM
S D J Med; 1991 Jun; 44(6):149-53. PubMed ID: 1947996
[TBL] [Abstract][Full Text] [Related]
12. [Sociodemographic profiles, addictive and mental comorbidity in cannabis users in an outpatient specific setting].
Guillem E; Pelissolo A; Vorspan F; Bouchez-Arbabzadeh S; Lépine JP
Encephale; 2009 Jun; 35(3):226-33. PubMed ID: 19540408
[TBL] [Abstract][Full Text] [Related]
13. [Party drugs cause dangerous poisonings. Risk of serious complications and death].
Knudsen K
Lakartidningen; 2011 Feb 2-8; 108(5):207-11. PubMed ID: 21384618
[No Abstract] [Full Text] [Related]
14. Recreational ecstasy use and the neurotoxic potential of MDMA: current status of the controversy and methodological issues.
Lyvers M
Drug Alcohol Rev; 2006 May; 25(3):269-76. PubMed ID: 16753651
[TBL] [Abstract][Full Text] [Related]
15. [Drug dependence among physicians].
Schifferdecker M; Schmidt R; Loevenich A; Krahl A
Z Arztl Fortbild (Jena); 1996 Jun; 90(4):295-300. PubMed ID: 8928528
[TBL] [Abstract][Full Text] [Related]
16. Specificity of genetic and environmental risk factors for symptoms of cannabis, cocaine, alcohol, caffeine, and nicotine dependence.
Kendler KS; Myers J; Prescott CA
Arch Gen Psychiatry; 2007 Nov; 64(11):1313-20. PubMed ID: 17984400
[TBL] [Abstract][Full Text] [Related]
17. The emergency care of cocaine intoxications.
Vroegop MP; Franssen EJ; van der Voort PH; van den Berg TN; Langeweg RJ; Kramers C
Neth J Med; 2009 Apr; 67(4):122-6. PubMed ID: 19581655
[TBL] [Abstract][Full Text] [Related]
18. Reduced memory and attention performance in a population-based sample of young adults with a moderate lifetime use of cannabis, ecstasy and alcohol.
Indlekofer F; Piechatzek M; Daamen M; Glasmacher C; Lieb R; Pfister H; Tucha O; Lange KW; Wittchen HU; Schütz CG
J Psychopharmacol; 2009 Jul; 23(5):495-509. PubMed ID: 18635709
[TBL] [Abstract][Full Text] [Related]
19. Impulsivity, risk taking and recreational 'ecstasy' (MDMA) use.
Butler GK; Montgomery AM
Drug Alcohol Depend; 2004 Oct; 76(1):55-62. PubMed ID: 15380289
[TBL] [Abstract][Full Text] [Related]
20. Analytical toxicology of emerging drugs of abuse--an update.
Meyer MR; Peters FT
Ther Drug Monit; 2012 Dec; 34(6):615-21. PubMed ID: 23131695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
